RadNet, Inc. cash flow statement RDNT

Annual Quarterly

In fiscal 2025, which ended Dec 31, 2025, RadNet, Inc. generated $298.8 million of cash from operations, up 28.2% from the year before.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.

Line	FY 2026 Jun 30, 2026	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020	FY 2019 Dec 31, 2019	FY 2018 Dec 31, 2018	FY 2017 Dec 31, 2017	FY 2013 Dec 31, 2013
Operating
Depreciation and amortization	171 +20.1%	152 +10.4%	138 +7.4%	128 +10.8%	116 +19.8%	97 +11.4%	87 +7.7%	81 +10.6%	73 +9.1%	67 +0.3%	5 +2.6%
Stock-based compensation	59 +17.6%	55 +83.0%	30 +11.4%	27 +12.7%	24 -5.7%	25 +103.2%	12 +42.1%	9 +13.9%	8 +12.9%	7 +16.5%	3 -5.9%
Operating cash flow	310 +18.5%	299 +28.2%	233 +5.5%	221 +50.8%	146 -2.1%	149 -36.0%	234 +124.1%	104 -10.6%	117 -17.9%	142	66 -11.8%
Investing
Capital expenditures	—	—	—	—	—	—	—	74 +2.7%	72 +17.7%	61 +3.5%	2 +80.1%
Investing cash flow	-624 -150.7%	-344 -47.5%	-233 -15.7%	-201 +18.4%	-247 -11.5%	-222 -75.5%	-126 -26.9%	-99 +32.2%	-147 -85.0%	-79	-51 +41.8%
Financing
Debt issued	—	99 -88.5%	864	—	—	—	—	—	—	—	—
Debt repaid	—	—	—	3	0 -100.0%	3 -7.3%	4 -45.1%	6 +6.9%	6 -11.2%	7 -42.5%	1 -59.7%
Short-term debt issued	—	—	—	—	—	—	—	97	0 -100.0%	165	—
Financing cash flow	210 +167.6%	72 -81.9%	398 +103.4%	196 +108.9%	94 -10.5%	105 +329.7%	-46 -282.6%	25 +329.6%	-11 +66.3%	-32	-8 -179.2%
Change in cash
Effect of exchange rate	-3 -1247.9%	0 +107.3%	-0 -55.1%	-0 -358.4%	0 +273.8%	-0 +35.6%	-0	—	—	—	—
Net change in cash	-107 -216.8%	27 -93.2%	397 +85.1%	215 +3270.9%	-7 -120.8%	33 -47.3%	62	—	—	—	—
Free cash flow	—	—	—	—	—	—	—	30 -32.3%	45 -44.9%	81	64 -13.1%
Per share
Free cash flow per share	—	—	—	—	—	—	—	0.60 -34.4%	0.92 -46.3%	1.71	1.62 -14.3%
Ratios
Free cash flow margin	—	—	—	—	—	—	—	2.61%	4.57%	8.77%	9.17%
Capital expenditures to revenue	—	—	—	—	—	—	—	6.42%	7.40%	6.65%	0.28%
Stock-based compensation to revenue	2.61%	2.68%	1.63%	1.66%	1.66%	1.92%	1.16%	0.76%	0.79%	0.74%	0.37%
Cash conversion	—	—	83.43x	72.56x	13.75x	6.05x	—	7.07x	3.62x	2,683.49x	5.75x

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry: Services-Medical Laboratories (SIC 8071)
Listed as: RDNT (Nasdaq)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Los Angeles, CA
SEC filer status: Large accelerated filer
SEC CIK: 790526
Former names: RadNet, Inc. (until Oct 26, 2026); PRIMEDEX HEALTH SYSTEMS INC (until Nov 21, 2006)

Other Services-Medical Laboratories companies

All 29 Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.